Home › Narcolepsy
Narcolepsy clinical trials recruiting in the U.S.
15 studies for Narcolepsy are recruiting participants at sites across the United States.
Cities with the most studies
- Cincinnati, OH7 studies
- Miami, FL7 studies
- Columbia, SC6 studies
- Charlotte, NC6 studies
- Austin, TX6 studies
- San Antonio, TX5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Sugar Land, TX4 studies
- Columbus, OH4 studies
- Brandon, FL4 studies
- Macon, GA4 studies
- Los Angeles, CA4 studies
- Redwood City, CA3 studies
- Colorado Springs, CO3 studies
- Farmington Hills, MI3 studies
- Boulder, CO3 studies
- Staten Island, NY3 studies
- Sterling Heights, MI3 studies
- Reading, PA3 studies
- Madison, WI3 studies
- Philadelphia, PA3 studies
- Kansas City, KS3 studies
- Lansing, MI3 studies
By state
- Alabama5 studies
- Arizona3 studies
- California8 studies
- Colorado4 studies
- Florida7 studies
- Georgia6 studies
- Kansas3 studies
- Michigan5 studies
- New Jersey3 studies
- North Carolina8 studies
- Ohio7 studies
- Pennsylvania4 studies
- South Carolina7 studies
- Texas6 studies
- Wisconsin4 studies
Recently updated studies
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07540364A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683Decreasing Nightmares in Adults With Narcolepsy
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06383806A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 29, 2026 · NCT07633301WAKIX® (Pitolisant) Pregnancy Registry
RecruitingObservational study
All ages · Women · Updated Jun 12, 2026 · NCT05536011A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620Extended-release Sodium Oxybate in Children
RecruitingPhase 2
Ages 7 to 17 · All sexes · Updated Nov 6, 2025 · NCT06809803Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingObservational study
All ages · All sexes · Updated May 29, 2025 · NCT01793168SUNOSI® (Solriamfetol) Pregnancy Registry
RecruitingObservational study
All ages · Women · Updated May 14, 2024 · NCT06413420From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.